<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><?release-delay 0|0 ?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="hwp">jbc</journal-id><journal-id journal-id-type="pmc">jbc</journal-id><journal-id journal-id-type="publisher-id">JBC</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name><publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3057819</article-id><article-id pub-id-type="publisher-id">M110.165274</article-id><article-id pub-id-type="doi">10.1074/jbc.M110.165274</article-id><article-categories><subj-group subj-group-type="heading"><subject>Membrane Biology</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="7527" pm="."><plain>Activation of Colicin M by the FkpA Prolyl Cis-Trans Isomerase/Chaperone* </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="short">Cma Activation by FkpA</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Helbig</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Patzer</surname><given-names>Silke I.</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schiene-Fischer</surname><given-names>Cordelia</given-names></name><xref ref-type="aff" rid="aff2"><sup>§</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeth</surname><given-names>Kornelius</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Braun</surname><given-names>Volkmar</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref><xref ref-type="corresp" rid="cor1"><sup>1</sup></xref></contrib><aff id="aff1">From the <label>‡</label>Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 Tübingen, Germany and </aff><aff id="aff2">the <label>§</label>Max Planck Research Unit of Enzymology of Protein Folding, 06120 Halle, Germany</aff></contrib-group><author-notes><corresp id="cor1"><label>1</label> To whom correspondence should be addressed. Tel.: <phone>49-7071-601343</phone>; Fax: <fax>49-7071-601349</fax>; E-mail: <email>volkmar.braun@tuebingen.mpg.de</email>.</corresp></author-notes><pub-date pub-type="ppub"><day>25</day><month>2</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>12</month><year>2010</year></pub-date><volume>286</volume><issue>8</issue><fpage>6280</fpage><lpage>6290</lpage><history><date date-type="received"><day>19</day><month>7</month><year>2010</year></date><date date-type="rev-recd"><day>12</day><month>11</month><year>2010</year></date></history><permissions><copyright-statement>© 2011 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement><license license-type="open-access"><license-p><italic>Author's Choice</italic>—Final version full access.</license-p><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc00811006280.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="7528" pm="."><plain>Colicin M (Cma) is specifically imported into the periplasm of Escherichia coli and kills the cells. </plain></SENT>
<SENT sid="7529" pm="."><plain>Killing depends on the periplasmic peptidyl prolyl cis-trans isomerase/chaperone FkpA. </plain></SENT>
<SENT sid="7530" pm="."><plain>To identify the Cma prolyl bonds targeted by FkpA, we replaced the 15 proline residues individually with alanine. </plain></SENT>
<SENT sid="7531" pm="."><plain>Seven mutant proteins were fully active; Cma(P129A), Cma(P176A), and Cma(P260A) displayed 1%, and Cma(P107A) displayed 10% of the wild-type activity. </plain></SENT>
<SENT sid="7532" pm="."><plain>Cma(P107A), Cma(P129A), and Cma(P260A), but not Cma(P176A), killed cells after entering the periplasm via osmotic shock, indicating that the former mutants were translocation-deficient; Cma(P129A) did not bind to the FhuA outer membrane receptor. </plain></SENT>
<SENT sid="7533" pm="."><plain>The crystal structures of Cma and Cma(P176A) were identical, excluding inactivation of the activity domain located far from Pro-176. </plain></SENT>
<SENT sid="7534" pm="."><plain>In a new peptidyl prolyl cis-trans isomerase assay, FkpA isomerized the Cma prolyl bond in peptide Phe-Pro-176 at a high rate, but Lys-Pro-107 and Leu-Pro-260 isomerized at only &lt;10% of that rate. </plain></SENT>
<SENT sid="7535" pm="."><plain>The four mutant proteins secreted into the periplasm via a fused signal sequence were toxic but much less than wild-type Cma. </plain></SENT>
<SENT sid="7536" pm="."><plain>Wild-type and mutant Cma proteins secreted or translocated across the outer membrane by energy-coupled import or unspecific osmotic shock were only active in the presence of FkpA. </plain></SENT>
<SENT sid="7537" pm="."><plain>We propose that Cma unfolds during transfer across the outer or cytoplasmic membrane and refolds to the active form in the periplasm assisted by FkpA. </plain></SENT>
<SENT sid="7538" pm="."><plain>Weak refolding of Cma(P176A) would explain its low activity in all assays. </plain></SENT>
<SENT sid="7539" pm="."><plain>Of the four proline residues identified as being important for Cma activity, Phe-Pro-176 is most likely targeted by FkpA. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Bacterial Toxins</kwd><kwd>Chaperone Chaperonin</kwd><kwd>Membrane Proteins</kwd><kwd>Protein Structure</kwd><kwd>Protein Translocation</kwd><kwd>Colicin</kwd><kwd>FkpA</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro"><title><text><SENT sid="7540" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="7541" pm="."><plain>Colicin M (Cma)2 is synthesized by Escherichia coli cells that carry a pColBM plasmid and is unspecifically released to a low extent. </plain></SENT>
<SENT sid="7542" pm="."><plain>It kills sensitive E. coli cells by interfering with lipid carrier recycling, leading to inhibition of murein biosynthesis and cell lysis (1, 2). </plain></SENT>
<SENT sid="7543" pm="."><plain>Specifically, Cma cleaves the phosphate ester bond between the lipid carrier (bactoprenol) and the murein precursor (3). </plain></SENT>
<SENT sid="7544" pm="."><plain>Cma enters the periplasm of sensitive cells by binding to the FhuA outer membrane receptor protein and translocation across the outer membrane by an energy-coupled mechanism through the action of the TonB, ExbB, and ExbD proteins (Ton system) (4–6). </plain></SENT>
</text></p><p><text><SENT sid="7545" pm="."><plain>Like all colicins, Cma consists of a central receptor binding domain, an N-terminal translocation domain, and a C-terminal activity domain (7), which can be seen in the crystal structure (8). </plain></SENT>
<SENT sid="7546" pm="."><plain>Only the activity domain, which starts at residue 124, is homologous with colicin-M-like proteins of other bacteria (8, 9). </plain></SENT>
</text></p><p><text><SENT sid="7547" pm="."><plain>The first E. coli mutants identified that were resistant to added colicin M were mutated in the fhuA, tonB, exbB, or exbD transport genes. </plain></SENT>
<SENT sid="7548" pm="."><plain>Another type of Cma-resistant mutant eluded genetic and function characterization (10) until recently. </plain></SENT>
<SENT sid="7549" pm="."><plain>We localized the mutation to the fkpA gene, which encodes a periplasmic peptidyl prolyl cis-trans isomerase (PPIase)/chaperone. </plain></SENT>
<SENT sid="7550" pm="."><plain>Among 10 colicins tested, only Cma requires FkpA for toxicity (11). </plain></SENT>
</text></p><p><text><SENT sid="7551" pm="."><plain>The function of FkpA for E. coli physiology, however, is not clear as fkpA mutants show no phenotype. </plain></SENT>
<SENT sid="7552" pm="."><plain>FkpA is overexpressed under stress conditions, partially controlled by σE through a σE promoter. </plain></SENT>
<SENT sid="7553" pm="."><plain>Deletion of fkpA stimulates transcription of degP, which encodes a heat shock-inducible periplasmic protease (12). </plain></SENT>
<SENT sid="7554" pm="."><plain>Overproduction of FkpA prevents the formation of periplasmic inclusion bodies of MalE31, a defective folding derivative of the MalE-binding protein (13), and increases the yield of functional engineered antibody fragments produced in E. coli (14). </plain></SENT>
</text></p><p><text><SENT sid="7555" pm="."><plain>FkpA displays high PPIase activity, as demonstrated by the refolding of ribonuclease T1 and prolyl cis-trans isomerization of oligopeptides (15). </plain></SENT>
<SENT sid="7556" pm="."><plain>Its activity is inhibited by FK506, an inhibitor of prokaryotic and eukaryotic FKBP-type PPIases (15). </plain></SENT>
<SENT sid="7557" pm="."><plain>FkpA forms a dimer; the monomers consist of an N-proximal helical domain (residues 1–114) and a C-proximal domain (residues 115–245) typical for the FKBP family of PPIases (16). </plain></SENT>
<SENT sid="7558" pm="."><plain>The five periplasmic PPIases/chaperones PpiA, PpiD, SurA, FkpA, and Skp usually act on various substrates and can functionally replace each other (17–19). </plain></SENT>
<SENT sid="7559" pm="."><plain>In contrast, the toxicity of Cma strictly depends on FkpA and not on any other E. coli PPIase/chaperone (11). </plain></SENT>
</text></p><p><text><SENT sid="7560" pm="."><plain>The strict dependence of Cma toxicity on FkpA prompted us to attempt to identify the prolyl bond targeted by FkpA. </plain></SENT>
<SENT sid="7561" pm="."><plain>If periplasmic Cma activity depends on the FkpA prolyl cis-trans isomerase function and not, or not only on the FkpA chaperone function, replacement of the proline residue that is cis-trans-isomerized should prevent activation. </plain></SENT>
<SENT sid="7562" pm="."><plain>To test this premise we replaced each of the 15 proline residues in Cma individually with alanine. </plain></SENT>
<SENT sid="7563" pm="."><plain>Here we identified one prolyl bond that could serve as the target of FkpA PPIase catalysis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods"><title><text><SENT sid="7564" pm="."><plain>EXPERIMENTAL PROCEDURES </plain></SENT>
</text></title><sec><title/><sec><title/><sec><title><text><SENT sid="7565" pm="."><plain>Bacterial Strains and Plasmids </plain></SENT>
</text></title><p><text><SENT sid="7566" pm="."><plain>The bacterial strains and plasmids used and their sources are listed in Table 1. </plain></SENT>
<SENT sid="7567" pm="."><plain>Isolation of the FkpA313 mutant SIP1275 and the temperature-sensitive FkpA43 mutant K458 was described previously (10, 11, 20). </plain></SENT>
</text></p><SecTag type="TABLE"></SecTag><p><text><SENT sid="8141" pm="."><plain>To further support the role of FkpA PPIase activity for Cma activity, we determined the catalytic efficiency toward the Phe-Pro-176-Val and Leu-Pro-260-Gly derivatives using the FkpA313 mutant protein, which contains a G148D replacement in the PPIase domain and does not mediate Cma sensitivity to cells (11). </plain></SENT>
<SENT sid="8142" pm="."><plain>Only a very low in vitro PPIase activity of FkpA313 was observed with both peptides; the activity amounted to 0.4 and 0.2% that of wild-type FkpA (Table 5). </plain></SENT>
<SENT sid="8143" pm="."><plain>The data were further corroborated by the temperature-sensitive mutant FkpA43, which confers 10% activity to Cma at 30 °C and no activity at 42 °C (11). </plain></SENT>
<SENT sid="8144" pm="."><plain>It displayed a 2-fold lower PPIase activity than wild-type FkpA for Phe-Pro-176-Val and a 5-fold lower activity for Leu-Pro-260-Gly than for Phe-Pro-176-Val (measured at 10 °C) (Table 5). </plain></SENT>
<SENT sid="8145" pm="."><plain>The near inactivity of mutant Cma(P176A) in lysing cells and the high efficiency of FkpA in the catalysis of the cis-trans isomerization of Phe-Pro-176-Val peptide suggest that Phe-Pro-176 is the Cma peptide bond that is most likely catalytically cis-trans isomerized by FkpA. </plain></SENT>
</text></p></sec></sec></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion"><title><text><SENT sid="8146" pm="."><plain>DISCUSSION </plain></SENT>
</text></title><p><text><SENT sid="8147" pm="."><plain>Periplasmic folding helper proteins interact with outer membrane proteins, and a considerable degree of redundancy and overlap in their function is observed (41–49). </plain></SENT>
<SENT sid="8148" pm="."><plain>For the periplasmic PPIases FkpA, PpiA, PpiD, and SurA of E. coli, no specificity for a distinct protein has been found, and no defined prolyl bond of a bacterial protein cis-trans isomerized by a PPIase has been identified yet. </plain></SENT>
<SENT sid="8149" pm="."><plain>The strict dependence of Cma toxicity on FkpA allowed us to search for a correlation between Cma activity and FkpA catalysis of cis-trans isomerization of a specific prolyl bond of Cma. </plain></SENT>
<SENT sid="8150" pm="."><plain>Using such an approach, we could identify a critical prolyl bond of Cma. </plain></SENT>
</text></p><p><text><SENT sid="8151" pm="."><plain>The 15 Cma proline-to-alanine replacement mutants encompassed all proline residues in Cma. </plain></SENT>
<SENT sid="8152" pm="."><plain>Three mutants showed a strongly reduced (1%) killing of E. coli. </plain></SENT>
<SENT sid="8153" pm="."><plain>A fourth mutant, Cma(P107A), had 10% of Cma wild-type activity in plate assays. </plain></SENT>
<SENT sid="8154" pm="."><plain>This mutant was interesting because Pro-107 forms the only prolyl cis peptide bond in Cma. </plain></SENT>
<SENT sid="8155" pm="."><plain>Strongly increased activity after bypassing the energy-coupled uptake by osmotic shock suggested that three mutant proteins (Cma(P107A), Cma(P129A), and Cma(P260A)) were impaired in uptake. </plain></SENT>
<SENT sid="8156" pm="."><plain>Indeed, Cma(P129A) did not bind to the FhuA receptor. </plain></SENT>
<SENT sid="8157" pm="."><plain>The translocation efficiency of Cma(P107A) was probably affected by the isomerization of the Lys-Pro cis bond to a Lys-Ala trans bond even though this conversion altered the protein crystal structure only locally. </plain></SENT>
<SENT sid="8158" pm="."><plain>Because the molecular mechanism of Cma translocation and in fact of any colicin across the outer membrane is unknown, it is not clear to what extent regions other than the translocation domain (residues 1–35) contribute to uptake across the outer membrane. </plain></SENT>
<SENT sid="8159" pm="."><plain>The same reasoning applies to Cma(P260A), whose mutation is not located in the translocation domain but, rather, in the activity domain. </plain></SENT>
</text></p><p><text><SENT sid="8160" pm="."><plain>Cma(P176A) was the only mutant with very low activity (1%) that remained nearly inactive when it was osmotically shocked into cells. </plain></SENT>
<SENT sid="8161" pm="."><plain>It also displayed the lowest activity when it was equipped with a signal sequence, which allowed it to be secreted from the cytoplasm into the periplasm. </plain></SENT>
<SENT sid="8162" pm="."><plain>Because the crystal structure of Cma(P176A) did not differ from the crystal structure of wild-type Cma, it is unlikely that the mutation affects the active center of Cma(P176A). </plain></SENT>
<SENT sid="8163" pm="."><plain>Pro-176 is exposed at the Cma surface (Fig. 1) and its conversion to A176 does not change the Cma structure beyond the mutation site. </plain></SENT>
</text></p><p><text><SENT sid="8164" pm="."><plain>Previous results indicate that Pro-176 is not in the active site of Cma (8, 9, 29). </plain></SENT>
<SENT sid="8165" pm="."><plain>Random and site-directed mutagenesis of cma localized the active center around residue D226, a strictly conserved residue in a region in which the Cma-type sequences display the highest level of identity (8, 9). </plain></SENT>
<SENT sid="8166" pm="."><plain>Pro-176 is located far from Asp-226 (Fig. 1). </plain></SENT>
<SENT sid="8167" pm="."><plain>If the P176A mutation affects Cma activity independent of catalysis by FkpA, the mutation must have a long distance structural effect on the active center; such an effect was not observed in the crystal structure. </plain></SENT>
<SENT sid="8168" pm="."><plain>We also found no evidence for a structural alteration of Cma(P176A) in solution; it acted like wild-type Cma with regard to proteinase K digestion, thermal denaturation, and urea denaturation. </plain></SENT>
</text></p><p><text><SENT sid="8169" pm="."><plain>FkpA exhibits PPIase and chaperone activities with artificial substrates (13, 15, 16). </plain></SENT>
<SENT sid="8170" pm="."><plain>FkpA reactivates Cma denatured with 5 m guanidine hydrochloride, which is inhibited by FK506 (11), an inhibitor of the PPIase activity. </plain></SENT>
<SENT sid="8171" pm="."><plain>In addition, the G148D mutation in the FkpA PPIase center abolishes Cma renaturation (11) and confers resistance to Cma. </plain></SENT>
<SENT sid="8172" pm="."><plain>Additional mutants in the PPIase domain and only in the PPIase domain, G176D and G180D, were isolated by independent random mutagenesis, which did not confer Cma sensitivity.3 Arié et al. (13) isolated by site-specific mutagenesis FkpA mutants I174S and I174S/G176S and found no or only 5% PPIase activity but unaltered chaperone activity using a standard protease-coupled peptide assay. </plain></SENT>
<SENT sid="8173" pm="."><plain>These mutants strongly favor the PPIase activity in Cma activation. </plain></SENT>
<SENT sid="8174" pm="."><plain>In this study Phe-Pro-176 is the only bond left for cis-trans isomerization. </plain></SENT>
<SENT sid="8175" pm="."><plain>The high catalytic efficiency of FkpA toward the Phe-Pro-176 peptide substrate, which was 14- and 12-fold higher than toward the Lys-Pro-107 and Leu-Pro-260 peptide substrates agrees with this proposal. </plain></SENT>
</text></p><p><text><SENT sid="8176" pm="."><plain>Pro-176 is exposed at the surface of Cma (Fig. 1) and can, thus, be approached by FkpA. </plain></SENT>
<SENT sid="8177" pm="."><plain>Pro-107 and -260 are also close to the surface but are less exposed than Pro-176. </plain></SENT>
<SENT sid="8178" pm="."><plain>Pro-129 is buried inside Cma and cannot be reached by FkpA unless strong structural alterations are induced by binding of Cma to FkpA before catalysis of cis-trans isomerization. </plain></SENT>
<SENT sid="8179" pm="."><plain>The location of the Phe-Pro-176 bond makes it the most likely candidate for cis-trans isomerization. </plain></SENT>
</text></p><p><text><SENT sid="8180" pm="."><plain>Despite strong evidence for the PPIase activity of FkpA in Cma activation, its chaperone activity should also be considered. </plain></SENT>
<SENT sid="8181" pm="."><plain>Cma(P176A) transferred into the periplasm by osmotic shock did not respond to FkpA as the residual activity was not altered in the fkpA deletion mutant (Table 4). </plain></SENT>
<SENT sid="8182" pm="."><plain>However, Cma(P176A) secreted from the cytoplasm into the periplasm by a signal sequence fused to Cma(P176A) stopped growth of the fkpA wild-type cells and failed to stop growth of the fkpA mutant. </plain></SENT>
<SENT sid="8183" pm="."><plain>Although this activity was weak and was only observed after increased synthesis of Cma(P176A), it nevertheless demonstrates some response of Cma(P176A) to FkpA. </plain></SENT>
<SENT sid="8184" pm="."><plain>We assign this activity to the chaperone function of FkpA in the periplasm. </plain></SENT>
<SENT sid="8185" pm="."><plain>However, an exclusive FkpA chaperone activity for activation of Cma would not show such a high site specificity as found for the inactive point mutants in the PPIase domain. </plain></SENT>
</text></p><p><text><SENT sid="8186" pm="."><plain>Cma must unfold at least partially during translocation across the outer membrane and, when fused to a signal sequence, during translocation across the cytoplasmic membrane. </plain></SENT>
<SENT sid="8187" pm="."><plain>Unfolding may convert the Phe-Pro-176 trans bond into a cis bond. Trans to cis isomerization also occurred in Cma mutant proteins in which Pro-176 was replaced by Ala, Gly, Leu, Val, Thr, Lys, and Asp. </plain></SENT>
<SENT sid="8188" pm="."><plain>These derivatives were all inactive or nearly inactive because the lack of Pro prevented FkpA-catalized cis to trans isomerization during refolding in the periplasm. </plain></SENT>
<SENT sid="8189" pm="."><plain>The conversion involves the PPIase, but the chaperone function of FkpA also contributes to Cma activation. </plain></SENT>
<SENT sid="8190" pm="."><plain>Direct determination of the cis to trans conversion is hampered by the few molecules of Cma in the periplasm, which are sufficient to kill cells (20) and the much larger unspecific adsorption of Cma to the cells. </plain></SENT>
<SENT sid="8191" pm="."><plain>In addition, we found no suitable wavelength at which fluorescence changes reflected structural changes during in vitro refolding of denatured Cma by FkpA (11). </plain></SENT>
<SENT sid="8192" pm="."><plain>Cma refolding may contribute energy for translocation. </plain></SENT>
<SENT sid="8193" pm="."><plain>In addition, FkpA may act as a chaperone that binds imported Cma and prevents proteolytic degradation of the unfolded protein. </plain></SENT>
<SENT sid="8194" pm="."><plain>Multiple functions of FkpA (Cma refolding, binding of Cma in the periplasm, and positioning of Cma to the substrate site) best explain the complete dependence of Cma activity on FkpA. </plain></SENT>
</text></p></sec></SecTag>
      <SecTag type="SUPPL"><sec sec-type="supplementary-material">
         <title><text><SENT sid="8195" pm="."><plain>Supplementary Material </plain></SENT>
</text></title>
         <supplementary-material id="PMC_1" content-type="local-data">
            <caption>
               <title><text><SENT sid="8196" pm="."><plain>Supplemental Data </plain></SENT>
</text></title>
            </caption>
            <media mimetype="text" mime-subtype="html" xlink:href="supp_286_8_6280__index.html"/>
            <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_M110.165274_jbc.M110.165274-1.pdf"/>
         </supplementary-material>
      </sec></SecTag>
   </body><back><fn-group><SecTag type="ACK_FUND"><fn fn-type="supported-by" id="FN1"><label>*</label><p><text4fund><text><SENT sid="8197" pm="."><plain>This work was supported by the Max Planck Society, the German Science Foundation (BR 30/25-1), and the Fonds der Chemischen Industrie. </plain></SENT>
</text></text4fund></p></fn></SecTag><SecTag type="SUPPL"><fn fn-type="supplementary-material" id="FN2"><label><inline-graphic xlink:href="sbox.jpg"/></label><p><text><SENT sid="8198" pm="."><plain>The on-line version of this article (available at <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Figs. S1–S4</ext-link>. </plain></SENT>
</text></p></fn></SecTag><fn fn-type="other"><p><text><SENT sid="8199" pm="."><plain>The atomic coordinates and structure factors (codes <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=2XMX">2XMX</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=2XTR">2XTR</ext-link>) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/">http://www.rcsb.org/</ext-link>). </plain></SENT>
</text></p></fn><fn fn-type="other" id="FN4"><label>3</label><p><text><SENT sid="8200" pm="."><plain>S. </plain></SENT>
<SENT sid="8201" pm="."><plain>I. </plain></SENT>
<SENT sid="8202" pm="."><plain>Patzer, unpublished results. </plain></SENT>
</text></p></fn></fn-group><fn-group content-type="abbreviations"><fn id="FN3"><label>2</label><p><text><SENT sid="8203" pm="."><plain>The abbreviations used are: Cmacolicin MPPIasepeptidyl prolyl cis-trans isomeraseNi-NTAnickel-nitrilotriacetic acidBis/Tris2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diolFKBPFK506-binding protein. </plain></SENT>
</text></p></fn></fn-group><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="8204" pm="."><plain>We thank Dr. Reinhard Albrecht and Kerstin Bär for valuable help in protein crystallization, Dr. Andrei Lupas for generous support, and Karen A. Brune for critically reading the manuscript. </plain></SENT>
<SENT sid="8206" pm="."><plain>We cordially thank the beamline staff from the Max Planck beamline PX10 at the Swiss Light Source for great help and beamline maintenance. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>REFERENCES</title><ref id="B1"><text><SENT sid="8207" pm="."><plain>1. SchallerK.HöltjeJ. </plain></SENT>
<SENT sid="8208" pm="."><plain>V.BraunV. (1982) J. Bacteriol. 152, 994–1000 6754708 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="8210" pm="."><plain>2. HarknessR. </plain></SENT>
<SENT sid="8211" pm="."><plain>E.BraunV. (1989) J. Biol. </plain></SENT>
<SENT sid="8213" pm="."><plain>Chem. 264, 6177–6182 2649496 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="8214" pm="."><plain>3. El GhachiM.BouhssA.BarreteauH.TouzéT.AugerG.BlanotD.Mengin-LecreulxD. (2006) J. Biol. </plain></SENT>
<SENT sid="8216" pm="."><plain>Chem. 281, 22761–22772 16777846 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="8217" pm="."><plain>4. BraunV. (1995) FEMS Microbiol. </plain></SENT>
<SENT sid="8218" pm="."><plain>Rev. 16, 295–307 7654405 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="8219" pm="."><plain>5. BraunV.PatzerS. </plain></SENT>
<SENT sid="8220" pm="."><plain>I.HantkeK. (2002) Biochimie 84, 365–380 12423780 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="8221" pm="."><plain>6. PostleK.LarsenR. </plain></SENT>
<SENT sid="8222" pm="."><plain>A. (2007) Biometals 20, 453–465 17225934 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="8223" pm="."><plain>7. DreherR.BraunV.Wittmann-LieboldB. (1985) Arch. </plain></SENT>
<SENT sid="8224" pm="."><plain>Microbiol. 140, 343–346 3985748 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="8225" pm="."><plain>8. ZethK.RömerC.PatzerS. </plain></SENT>
<SENT sid="8226" pm="."><plain>I.BraunV. (2008) J. Biol. </plain></SENT>
<SENT sid="8228" pm="."><plain>Chem. 283, 25324–25331 18640984 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="8229" pm="."><plain>9. BarreteauH.BouhssA.GérardF.DuchéD.BoussaidB.BlanotD.LloubèsR.Mengin-LecreulxD.TouzéT. (2010) J. Biol. </plain></SENT>
<SENT sid="8231" pm="."><plain>Chem. 285, 12378–12389 20159977 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="8232" pm="."><plain>10. BraunV.FrenzJ.HantkeK.SchallerK. (1980) J. Bacteriol. 142, 162–168 6989802 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="8234" pm="."><plain>11. HullmannJ.PatzerS. </plain></SENT>
<SENT sid="8235" pm="."><plain>I.RömerC.HantkeK.BraunV. (2008) Mol. </plain></SENT>
<SENT sid="8236" pm="."><plain>Microbiol. 69, 926–937 18554332 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="8237" pm="."><plain>12. DaneseP. </plain></SENT>
<SENT sid="8238" pm="."><plain>N.SilhavyT. </plain></SENT>
<SENT sid="8239" pm="."><plain>J. (1997) Genes Dev. 11, 1183–1193 9159399 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="8240" pm="."><plain>13. AriéJ. </plain></SENT>
<SENT sid="8241" pm="."><plain>P.SassoonN.BettonJ. </plain></SENT>
<SENT sid="8242" pm="."><plain>M. (2001) Mol. </plain></SENT>
<SENT sid="8243" pm="."><plain>Microbiol. 39, 199–210 11123702 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="8244" pm="."><plain>14. BothmannH.PluckthunA. (2000) J. Biol. </plain></SENT>
<SENT sid="8246" pm="."><plain>Chem. 275, 17100–17105 10748200 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="8247" pm="."><plain>15. RammK.PlückthunA. (2001) J. Mol. </plain></SENT>
<SENT sid="8249" pm="."><plain>Biol. 310, 485–498 11428902 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="8250" pm="."><plain>16. SaulF. </plain></SENT>
<SENT sid="8251" pm="."><plain>A.AriéJ. </plain></SENT>
<SENT sid="8252" pm="."><plain>P.Vulliez-le NormandB.KahnR.BettonJ. </plain></SENT>
<SENT sid="8253" pm="."><plain>M.BentleyG. </plain></SENT>
<SENT sid="8254" pm="."><plain>A. (2004) J. Mol. </plain></SENT>
<SENT sid="8256" pm="."><plain>Biol. 335, 595–608 14672666 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="8257" pm="."><plain>17. BettonJ. </plain></SENT>
<SENT sid="8258" pm="."><plain>M. (2007) in The Periplasm (EhrmannM. ed) pp. 141–149, American Society for Microbiology, Washington, D. C </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="8260" pm="."><plain>18. KleinschmidtJ. </plain></SENT>
<SENT sid="8261" pm="."><plain>H. (2007) in The Periplasm (EhrmannM. ed) pp. 30–66, American Society for Microbiology, Washington, D. C </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="8263" pm="."><plain>19. MogensenJ. </plain></SENT>
<SENT sid="8264" pm="."><plain>E.OtzenD. </plain></SENT>
<SENT sid="8265" pm="."><plain>E. (2005) Mol. </plain></SENT>
<SENT sid="8266" pm="."><plain>Microbiol. 57, 326–346 15978068 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="8267" pm="."><plain>20. SchallerK.DreherR.BraunV. (1981) J. Bacteriol. 146, 54–63 7012126 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="8269" pm="."><plain>21. KabschW. (2010) Acta. </plain></SENT>
<SENT sid="8270" pm="."><plain>Crystallogr. </plain></SENT>
<SENT sid="8271" pm="."><plain>D Biol. </plain></SENT>
<SENT sid="8272" pm="."><plain>Crystallogr. 66b, 125–13220124692 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="8273" pm="."><plain>22. PottertonE.BriggsP.TurkenburgM.DodsonE. (2003) Acta. </plain></SENT>
<SENT sid="8274" pm="."><plain>Crystallogr. </plain></SENT>
<SENT sid="8275" pm="."><plain>D Biol. </plain></SENT>
<SENT sid="8276" pm="."><plain>Crystallogr. 59, 1131–1137 12832755 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="8277" pm="."><plain>23. EmsleyP.CowtanK. (2004) Acta. </plain></SENT>
<SENT sid="8278" pm="."><plain>Crystallogr. </plain></SENT>
<SENT sid="8279" pm="."><plain>D Biol. </plain></SENT>
<SENT sid="8280" pm="."><plain>Crystallogr. 60, 2126–2132 15572765 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="8281" pm="."><plain>24. LaskowskiR. </plain></SENT>
<SENT sid="8282" pm="."><plain>A.MossD. </plain></SENT>
<SENT sid="8283" pm="."><plain>S.ThorntonJ. </plain></SENT>
<SENT sid="8284" pm="."><plain>M. (1993) J. Mol. </plain></SENT>
<SENT sid="8286" pm="."><plain>Biol. 231, 1049–1067 8515464 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="8287" pm="."><plain>25. KabschW.SanderC. (1983) Biopolymers 22, 2577–2637 6667333 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="8288" pm="."><plain>26. ThummG.OlschlägerT.BraunV. (1988) Plasmid 20, 75–82 2853881 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="8289" pm="."><plain>27. NossalN. </plain></SENT>
<SENT sid="8290" pm="."><plain>G.HeppelL. </plain></SENT>
<SENT sid="8291" pm="."><plain>A. (1966) J. Biol. </plain></SENT>
<SENT sid="8293" pm="."><plain>Chem. 241, 3055–3062 4287907 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="8294" pm="."><plain>28. TilbyM.HindennachI.HenningU. (1978) J. Bacteriol. 136, 1189–1191 363693 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="8296" pm="."><plain>29. PilslH.GlaserC.GrossP.KillmannH.OlschlägerT.BraunV. (1993) Mol. </plain></SENT>
<SENT sid="8297" pm="."><plain>Gen. </plain></SENT>
<SENT sid="8298" pm="."><plain>Genet. 240, 103–112 8341256 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="8299" pm="."><plain>30. KadnerR. </plain></SENT>
<SENT sid="8300" pm="."><plain>J.HellerK. </plain></SENT>
<SENT sid="8301" pm="."><plain>J. (1995) J. Bacteriol. 177, 4829–4935 7665457 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="8303" pm="."><plain>31. HarknessR. </plain></SENT>
<SENT sid="8304" pm="."><plain>E.BraunV. (1990) Mol. </plain></SENT>
<SENT sid="8305" pm="."><plain>Gen. </plain></SENT>
<SENT sid="8306" pm="."><plain>Genet. 222, 37–40 2233679 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="8307" pm="."><plain>32. OlschlägerT.TurbaA.BraunV. (1991) Mol. </plain></SENT>
<SENT sid="8308" pm="."><plain>Microbiol. 5, 1105–1111 1956288 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="8309" pm="."><plain>33. GrossP.BraunV. (1996) Mol. </plain></SENT>
<SENT sid="8310" pm="."><plain>Gen. </plain></SENT>
<SENT sid="8311" pm="."><plain>Genet. 251, 388–396 8676883 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="8312" pm="."><plain>34. OlschlägerT. (1991) Arch. </plain></SENT>
<SENT sid="8313" pm="."><plain>Microbiol. 156, 449–454 1785952 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="8314" pm="."><plain>35. GuzmanL. </plain></SENT>
<SENT sid="8315" pm="."><plain>M.BelinD.CarsonM. </plain></SENT>
<SENT sid="8316" pm="."><plain>J.BeckwithJ. (1995) J. Bacteriol. 177, 4121–4130 7608087 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="8318" pm="."><plain>36. BensonS. </plain></SENT>
<SENT sid="8319" pm="."><plain>A.BremerE.SilhavyT. </plain></SENT>
<SENT sid="8320" pm="."><plain>J. (1984) Proc. </plain></SENT>
<SENT sid="8321" pm="."><plain>Natl. </plain></SENT>
<SENT sid="8322" pm="."><plain>Acad. </plain></SENT>
<SENT sid="8323" pm="."><plain>Sci. </plain></SENT>
<SENT sid="8324" pm="."><plain>U.S.A. 81, 3830–3834 6374667 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="8325" pm="."><plain>37. Schiene-FischerC.HabazettlJ.SchmidF. </plain></SENT>
<SENT sid="8326" pm="."><plain>X.FischerG. (2002) Nat. </plain></SENT>
<SENT sid="8327" pm="."><plain>Struct. </plain></SENT>
<SENT sid="8328" pm="."><plain>Biol. 9, 419–424 12021775 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="8329" pm="."><plain>38. FischerG.AumüllerT. (2003) Rev. </plain></SENT>
<SENT sid="8330" pm="."><plain>Physiol. </plain></SENT>
<SENT sid="8331" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="8332" pm="."><plain>Pharmacol. 148, 105–150 12698322 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="8333" pm="."><plain>39. WeisshoffH.FrostK.BrandtW.HenkleinP.MüggeC.FrömmelC. (1995) FEBS Lett. 372, 203–209 7556670 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="8334" pm="."><plain>40. HarrisonR. </plain></SENT>
<SENT sid="8335" pm="."><plain>K.SteinR. </plain></SENT>
<SENT sid="8336" pm="."><plain>L. (1990) Biochemistry 29, 3813–3816 1693856 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="8337" pm="."><plain>41. ChenR.HenningU. (1996) Mol. </plain></SENT>
<SENT sid="8338" pm="."><plain>Microbiol. 19, 1287–1294 8730870 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="8339" pm="."><plain>42. JusticeS. </plain></SENT>
<SENT sid="8340" pm="."><plain>S.HunstadD. </plain></SENT>
<SENT sid="8341" pm="."><plain>A.HarperJ. </plain></SENT>
<SENT sid="8342" pm="."><plain>R.DuguayA. </plain></SENT>
<SENT sid="8343" pm="."><plain>R.PinknerJ. </plain></SENT>
<SENT sid="8344" pm="."><plain>S.BannJ.FriedenC.SilhavyT. </plain></SENT>
<SENT sid="8345" pm="."><plain>J.HultgrenS. </plain></SENT>
<SENT sid="8346" pm="."><plain>J. (2005) J. Bacteriol. 187, 7680–7686 16267292 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="8348" pm="."><plain>43. QuJ.MayerC.BehrensS.HolstO.KleinschmidtJ. </plain></SENT>
<SENT sid="8349" pm="."><plain>H. (2007) J. Mol. </plain></SENT>
<SENT sid="8351" pm="."><plain>Biol. 374, 91–105 17928002 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="8352" pm="."><plain>44. RizzitelloA. </plain></SENT>
<SENT sid="8353" pm="."><plain>E.HarperJ. </plain></SENT>
<SENT sid="8354" pm="."><plain>R.SilhavyT. </plain></SENT>
<SENT sid="8355" pm="."><plain>J. (2001) J. Bacteriol. 183, 6794–6800 11698367 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="8357" pm="."><plain>45. RouvièreP. </plain></SENT>
<SENT sid="8358" pm="."><plain>E.GrossC. </plain></SENT>
<SENT sid="8359" pm="."><plain>A. (1996) Genes Dev. 10, 3170–3182 8985185 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="8360" pm="."><plain>46. SchäferU.BeckK.MüllerM. (1999) J. Biol. </plain></SENT>
<SENT sid="8362" pm="."><plain>Chem. 274, 24567–24574 10455120 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="8363" pm="."><plain>47. SklarJ. </plain></SENT>
<SENT sid="8364" pm="."><plain>G.WuT.KahneD.SilhavyT. </plain></SENT>
<SENT sid="8365" pm="."><plain>J. (2007) Genes Dev. 21, 2473–2484 17908933 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="8366" pm="."><plain>48. StymestK. </plain></SENT>
<SENT sid="8367" pm="."><plain>H.KlappaP. (2008) FEBS 275, 3470–3479  </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="8368" pm="."><plain>49. VertommenD.RuizN.LeverrierP.SilhavyT. </plain></SENT>
<SENT sid="8369" pm="."><plain>J.ColletJ. </plain></SENT>
<SENT sid="8370" pm="."><plain>F. (2009) Proteomics 9, 2432–2443 19343722 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="8371" pm="."><plain>50. StudierF. </plain></SENT>
<SENT sid="8372" pm="."><plain>W.MoffattB. </plain></SENT>
<SENT sid="8373" pm="."><plain>A. (1986) J. Mol. </plain></SENT>
<SENT sid="8375" pm="."><plain>Biol. 189, 113–130 3537305 </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="8376" pm="."><plain>51. MendeJ.BraunV. (1990) Mol. </plain></SENT>
<SENT sid="8377" pm="."><plain>Microbiol. 4, 1523–1533 2287276 </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="8378" pm="."><plain>52. HanahanD. (1983) J. Mol. </plain></SENT>
<SENT sid="8380" pm="."><plain>Biol. 166, 557–580 6345791 </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="8381" pm="."><plain>53. TaborS.RichardsonC. </plain></SENT>
<SENT sid="8382" pm="."><plain>C. (1985) Proc. </plain></SENT>
<SENT sid="8383" pm="."><plain>Natl. </plain></SENT>
<SENT sid="8384" pm="."><plain>Acad. </plain></SENT>
<SENT sid="8385" pm="."><plain>Sci. </plain></SENT>
<SENT sid="8386" pm="."><plain>U.S.A. 82, 1074–1078 3156376 </plain></SENT>
</text></ref><ref id="B54"><text><SENT sid="8387" pm="."><plain>54. BraunM.EndrissF.KillmannH.BraunV. (2003) J. Bacteriol. 185, 5508–551812949103 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
